Drug Profile
Research programme: anti-infective vaccines - Novartis Vaccines
Alternative Names: Candida vaccine - Novartis; Candidiasis vaccine - Novartis; GAS vaccine - Novartis; Group A streptococcus vaccine - NovartisLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Novartis Vaccines
- Class Bacterial vaccines; Fungal vaccines; Streptococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Candidiasis; Streptococcal infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Candidiasis in USA (Parenteral)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Streptococcal-infections in USA (Parenteral)
- 30 Sep 2011 Preclinical development is ongoing